Subjects | Genotype | N | Serum ACE2 level (ng/mL) | MI severity score | |
---|---|---|---|---|---|
Total | Control | GG | 269 | 6.8±4.5 | N/A |
GA+AA | 91 | 5.5±3.3 | |||
Total | 360 | 6.3±3.9 | |||
Acute MI | GG | 257 | 15.9±7.8a | 11.6±6.5 | |
GA+AA | 94 | 8.1±5.4b,c | 18.8±4.4c | ||
Total | 351 | 13.7±7.2 | 13.5±4.9 | ||
Male | Control | GG | 144 | 6.6±4.7 | N/A |
GA+AA | 63 | 5.2±3.5 | |||
Total | 207 | 6.2±4.2 | |||
Acute MI | GG | 156 | 15.7±8.0a | 11.7±6.7 | |
GA+AA | 69 | 7.8±5.5b,c | 19.0±4.6c | ||
Total | 225 | 13.3±7.5 | 13.8±5.2 | ||
Female | Control | GG | 125 | 7.0±4.4 | N/A |
GA+AA | 28 | 6.2±3.1 | |||
Total | 153 | 6.9±3.5 | |||
Acute MI | GG | 101 | 16.2±7.5a | 11.4±6.2 | |
GA+AA | 25 | 8.9±5.2b,c | 18.2±4.0c | ||
 |  | Total | 126 | 14.8±8.0 | 12.8±4.4 |